Literature DB >> 34141075

PROTAC-Mediated Degradation of Janus Kinase as a Therapeutic Strategy for Cancer and Rheumatoid Arthritis.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 34141075      PMCID： PMC8201481          DOI： 10.1021/acsmedchemlett.1c00245

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors.

Authors:  Sukhvir Kaur; Yogita Bansal; Raj Kumar; Gulshan Bansal
Journal:  Bioorg Med Chem       Date:  2020-01-20       Impact factor: 3.641

Review 2.  Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance.

Authors:  Akudo Nwaogu; Ashley Bond; Philip J Smith
Journal:  Frontline Gastroenterol       Date:  2020-06-10

Review 3.  Anticancer Agents Based on Vulnerable Components in a Signalling Pathway.

Authors:  Ankur Vaidya; Shweta Jain; Sanjeev Sahu; Pankaj Kumar Jain; Kamla Pathak; Devender Pathak; Raj Kumar; Sanjay Kumar Jain
Journal:  Mini Rev Med Chem       Date:  2020       Impact factor: 3.862

4.  COVID-19 transmission through host cell directed network of GPCR.

Authors:  Yogendra Singh; Gaurav Gupta; Saurabh Satija; Kavita Pabreja; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Drug Dev Res       Date:  2020-04-23       Impact factor: 4.360

Review 5.  Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review.

Authors:  Paul Emery; Patrick Durez; Axel J Hueber; Inmaculada de la Torre; Esbjörn Larsson; Thorsten Holzkämper; Yoshiya Tanaka
Journal:  Arthritis Res Ther       Date:  2021-01-04       Impact factor: 5.156
  5 in total
  1 in total

Review 1.  Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.

Authors:  Yanhong Ni; Jun T Low; John Silke; Lorraine A O'Reilly
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.